May 30, 2015 Khoury et al ASCO AST - VAC1 Presentation Long - term Follow - up of Patients with Acute Myelogenous Leukemia
Receiving an Autologous Telomerase - based Dendritic Cell Vaccine
37 patients
received autologous MSCs via intrathecal injection, rather than direct spinal cord injection, in two monthly doses, and were then followed up at 6 months with responders (ALS - R) and non-responders (ALS - N) identified using the revised ALS functional rating scale (ALSFRS - R).
Not exact matches
The researchers also note that more women are
receiving implants rather than recreating breasts using tissue from other parts of their body, called
autologous reconstruction.
Diagnosed with multiple myeloma or lymphoma and prescribed an
autologous stem cell transplant (patient
receiving their own stem cells)
Patients
receive one of two types of stem cell - based transplants:
autologous, in which a patient donates and
receives back his / her own stem cells; or allogeneic, in which bone marrow - derived stem cells come from a related or unrelated donor whose human leukocyte antigens (HLA) are genetically matched with those of a patient.
Transplants types are categorized by the source of the donor:
Autologous transplants: Patients
receive their own stem cells.